background
mump
vaccin
prevent
diseas
typic
present
unilater
bilater
parot
februari
mump
reemerg
univers
student
nova
scotia
despit
highli
sensit
method
mump
viru
detect
case
peak
outbreak
laboratori
confirm
object
due
low
posit
rate
studi
investig
whether
infect
viral
pathogen
caus
mumpslik
present
outbreak
studi
design
buccal
specimen
patient
present
unilater
bilater
parot
neg
laboratori
test
mump
viru
test
epsteinbarr
viru
ebv
cytomegaloviru
cmv
quantit
pcr
differ
viral
marker
use
luminex
xtag
respiratori
viru
panel
rvp
companion
sera
buccal
specimen
avail
ebv
cmv
serolog
differenti
acut
infect
reactiv
result
correl
observ
sinc
viral
pathogen
detect
parot
nonparot
group
conclus
although
cocircul
viral
pathogen
mump
outbreak
differ
observ
preval
patient
present
without
parot
low
posit
rate
specimen
submit
mump
diagnost
like
result
increas
public
health
messag
physician
inexperi
recogn
mump
infect
suggest
clinic
acumen
mump
diagnosi
base
sole
clinic
present
low
background
mump
vaccin
prevent
diseas
typic
present
unilater
bilater
parot
februari
mump
reemerg
univers
student
nova
scotia
despit
highli
sensit
method
mump
viru
detect
case
peak
outbreak
laboratori
confirm
object
due
low
posit
rate
studi
investig
whether
infect
viral
pathogen
caus
mumpslik
present
outbreak
studi
design
buccal
specimen
patient
present
unilater
bilater
parot
neg
laboratori
test
mump
viru
test
epsteinbarr
viru
ebv
cytomegaloviru
cmv
quantit
pcr
differ
viral
marker
use
luminex
xtag
respiratori
viru
panel
rvp
companion
sera
buccal
specimen
avail
ebv
cmv
serolog
differenti
acut
infect
reactiv
result
correl
observ
sinc
viral
pathogen
detect
parot
nonparot
group
conclus
although
cocircul
viral
pathogen
mump
outbreak
differ
observ
preval
patient
present
without
parot
low
posit
rate
specimen
submit
mump
diagnost
like
result
increas
public
health
messag
physician
inexperi
recogn
mump
infect
suggest
clinic
acumen
mump
diagnosi
base
sole
clinic
present
low
elsevi
bv
right
reserv
clinic
mump
defin
acut
onset
unilater
bilater
tender
selflimit
swell
parotid
salivari
gland
last
day
without
appar
caus
howev
mump
infect
asymptomat
associ
nonspecif
respiratori
symptom
februari
mump
reemerg
univers
student
nova
scotia
height
outbreak
februari
juli
laboratori
perform
pcr
test
mump
viru
approxim
patient
posit
pcr
result
obtain
yield
posit
rate
low
posit
rate
highlight
difficulti
diagnos
mump
infect
base
sole
clinic
present
howev
possibl
infect
circul
virus
could
mimic
mump
yet
explor
correspond
author
divis
microbiolog
depart
patholog
attempt
explain
low
posit
rate
rtpcr
test
molecular
method
use
investig
whether
viral
pathogen
caus
mumpslik
present
cocircul
nova
scotia
mump
outbreak
small
subset
specimen
collect
outbreak
use
studi
total
nucleic
acid
extract
use
autom
magnapur
lc
roch
diagnost
branchburg
nj
buccal
specimen
collect
patient
present
without
parot
test
neg
mump
revers
transcriptas
polymeras
chain
reaction
rtpcr
serolog
specimen
test
presenc
respiratori
virus
use
xtag
rvp
test
luminex
molecular
diagnost
toronto
ontario
detect
influenza
b
parainfluenza
virus
piv
respiratori
syncyti
viru
b
adenoviru
human
metapneumoviru
rhinovirusenteroviru
includ
coxsacki
virus
associ
parot
coronavirus
sar
cov
perform
lightcycl
platform
roch
diagnost
branchburg
nj
determin
presenc
ebv
cmv
use
artu
ebv
lightcycl
lc
pcr
artu
cmv
lc
pcr
kit
qiagen
inc
mississauga
respect
resolv
whether
presenc
ebv
cmv
due
reactiv
rather
primari
infect
companion
sera
submit
time
buccal
specimen
test
serolog
evid
acut
infect
studi
approv
capit
health
research
ethic
board
sampl
collect
previous
annonam
patient
identifi
prior
test
specimen
submit
patient
assess
physician
possibl
mump
felt
parot
assess
nova
scotia
public
health
fig
median
age
group
year
year
femal
remain
evid
parot
use
compar
group
median
age
age
distribut
gender
ratio
parot
group
year
year
femal
overal
differ
virus
identifi
two
group
parainfluenza
influenza
ebv
detect
patient
bilater
parot
adenoviru
ebv
identifi
unilater
parot
group
fig
nonparot
group
parainfluenza
hmpv
rhinoviru
ebv
identifi
cmv
detect
group
specimen
ebv
detect
nonparot
parot
group
companion
sera
evalu
serolog
evid
primari
infect
reactiv
defin
presenc
ebv
viral
capsid
antigen
vca
igm
absenc
antiebv
nuclear
antigen
ebna
igg
parot
group
nonparot
group
found
acut
ebv
infect
remain
patient
detect
ebv
antiebna
igg
suggest
viral
shed
due
reactiv
rather
primari
diseas
averag
viral
load
acut
infect
log
significantli
higher
p
shed
due
reactiv
log
part
outbreak
manag
nova
scotia
health
promot
protect
nshpp
develop
case
definit
differ
slightli
definit
nova
scotia
outbreak
person
could
classifi
confirm
case
mump
absenc
posit
laboratori
test
present
bilater
parot
regardless
whether
epidemiolog
linkag
known
case
mump
criterion
includ
sinc
assum
likelihood
pathogen
mump
caus
bilater
parot
low
howev
possibl
viral
caus
cohort
explor
although
viral
pathogen
identifi
studi
number
small
distribut
equal
patient
without
parot
suggest
correl
howev
viral
pathogen
identifi
patient
bilater
parot
suggest
bilater
parot
alon
use
without
laboratori
confirm
diagnosi
mump
literatur
implic
virus
mumpslik
ill
rel
spars
report
case
includ
parot
complic
acut
ebv
infect
influenza
recent
aetiolog
mumpslik
ill
finnish
children
examin
use
serolog
use
serolog
test
mumpsneg
patient
viral
caus
identifi
case
parotid
swell
includ
ebv
piv
adenoviru
enteroviru
parvoviru
human
herp
viru
type
studi
date
use
molecular
method
pcr
systemat
identifi
viral
pathogen
patient
present
parot
mump
outbreak
number
limit
studi
possibl
patient
present
mumpslik
ill
caus
facial
swell
lymphaden
noninfecti
caus
parotid
stone
secondli
nasopharyng
swab
ideal
specimen
detect
respiratori
virus
suboptim
sampl
buccal
specimen
may
lead
estim
true
preval
virus
addit
sinc
outbreak
specimen
collect
use
standard
viral
transport
media
contain
antibiot
bacteri
caus
parot
could
evalu
also
possibl
virus
test
could
contribut
clinic
present
patient
addit
patient
studi
could
truli
mump
fals
neg
rtpcr
result
although
rtpcr
buccal
specimen
best
diagnost
test
mump
sensit
rtpcr
outbreak
also
possibl
specimen
collect
late
onset
symptom
yield
posit
rtpcr
result
howev
major
specimen
submit
first
day
symptom
viral
shed
maxim
first
studi
use
molecular
method
systemat
identifi
viral
pathogen
patient
present
parot
mump
outbreak
although
viral
pathogen
circul
mump
outbreak
fail
show
correl
parot
viral
pathogen
could
mimic
clinic
present
mump
infect
like
explan
low
posit
rate
may
simpli
result
increas
public
health
messag
uk
lead
increas
rate
report
front
line
clinician
addit
major
patient
nova
scotia
outbreak
one
dose
mump
contain
vaccin
partial
immun
like
modifi
clinic
present
mump
infect
includ
minim
enlarg
salivari
gland
lower
viral
shed
make
laboratori
confirm
difficult
conclus
say
physician
inexperienc
directli
survey
regard
experi
low
preval
diseas
decad
preced
outbreak
suggest
mani
physician
would
seen
case
mump
career
possibl
inexperi
combin
possibl
atyp
present
increas
public
health
messag
led
increas
specimen
submiss
patient
nonspecif
symptom
reflect
difficulti
diagnos
mump
partial
immun
popul
challeng
face
front
line
clinician
outbreak
